Abzena and Mabqi have announced a partnership integrating antibody discovery capabilities with development and manufacturing ...
Alvotech and Advanz Pharma have announced the receipt of marketing authorisations from the MHRA for all four formulations of ...
Caplyta (lumateperone) has scored a label extension into the depression setting, underscoring the belief Johnson & Johnson (J ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback